The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Given Bruce D since 2005.
The trader's CIK number is 1219384.
At the time of the last reporting, Given Bruce D was the CEO of Arrowhead Pharmaceuticals, Inc.. (stock ticker symbol ARWR).
Also see all insider trading activities at Arrowhead Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2005 | ENCY | 2,000 | $19,454 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ARWR | 0 | $0 | 64,529 | $3,304,460 | 20,653 | $153,075 |
| 2019 | ARWR | 0 | $0 | 679,750 | $10,665,245 | 206,000 | $458,687 |
| 2018 | ARWR | 0 | $0 | 40,000 | $208,400 | 0 | $0 |
1. Encysive Pharmaceuticals Inc (ENCY)
2. Arrowhead Pharmaceuticals, Inc. (ARWR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2005-10-11 | ENCY | Buy | 2,000 | 9.73 | 19,454 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-04-28 | ARWR | Sale | 5,101 | 40.00 | 204,040 |
| 2020-04-27 | ARWR | Option Ex | 200 | 5.19 | 1,038 |
| 2020-04-28 | ARWR | Option Ex | 4,197 | 7.49 | 31,418 |
| 2020-04-27 | ARWR | Sale | 300 | 40.00 | 12,000 |
| 2020-04-20 | ARWR | Option Ex | 16,256 | 7.42 | 120,619 |
| 2020-04-20 | ARWR | Sale | 23,515 | 40.00 | 940,600 |
| 2020-01-06 | ARWR | Sale | 35,613 | 60.31 | 2,147,820 |
| 2019-03-01 | ARWR | Option Ex | 42,500 | 2.01 | 85,424 |
| 2019-03-01 | ARWR | Sale | 42,500 | 19.99 | 849,574 |
| 2019-02-25 | ARWR | Option Ex | 42,500 | 2.01 | 85,424 |
| 2019-02-25 | ARWR | Sale | 42,500 | 18.98 | 806,650 |
| 2019-02-15 | ARWR | Sale | 26,250 | 17.67 | 463,837 |
| 2019-02-19 | ARWR | Option Ex | 42,500 | 2.01 | 85,424 |
| 2019-02-19 | ARWR | Sale | 42,500 | 17.98 | 764,150 |
| 2019-02-08 | ARWR | Option Ex | 11,667 | 2.62 | 30,567 |
| 2019-02-08 | ARWR | Sale | 46,167 | 15.34 | 708,201 |
| 2019-02-11 | ARWR | Option Ex | 11,667 | 2.62 | 30,567 |
| 2019-02-12 | ARWR | Option Ex | 42,500 | 2.01 | 85,424 |
| 2019-02-11 | ARWR | Sale | 154,167 | 16.07 | 2,477,463 |
| 2019-02-12 | ARWR | Sale | 42,500 | 17.06 | 725,050 |
| 2019-02-05 | ARWR | Sale | 22,500 | 14.48 | 325,800 |
| 2019-02-01 | ARWR | Sale | 28,500 | 13.85 | 394,725 |
| 2019-01-23 | ARWR | Sale | 17,500 | 13.15 | 230,125 |
| 2019-01-22 | ARWR | Sale | 152,000 | 13.59 | 2,065,680 |
| 2019-01-14 | ARWR | Option Ex | 12,666 | 4.41 | 55,857 |
| 2019-01-14 | ARWR | Sale | 42,666 | 14.40 | 614,390 |
| 2019-01-02 | ARWR | Sale | 20,000 | 11.98 | 239,600 |
| 2018-03-05 | ARWR | Sale | 20,000 | 6.73 | 134,600 |
| 2018-01-01 | ARWR | Sale | 20,000 | 3.69 | 73,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Given Bruce D (CEO of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.